The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution
Author:
- 1 July 2016
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 90, 8-13
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Achieving Continuous Manufacturing for Final Dosage Formation: Challenges and How to Meet Them May 20–21 2014 Continuous Manufacturing SymposiumJournal of Pharmaceutical Sciences, 2015
- First FDA Authorization for Next-Generation SequencerNew England Journal of Medicine, 2013
- Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study dataNature Biotechnology, 2013
- How Long Must Humans Live?The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2013
- Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)European Journal of Pharmaceutical Sciences, 2012
- Predictive, preventive, personalized and participatory medicine: back to the futureGenome Medicine, 2010
- Digital Disease Detection — Harnessing the Web for Public Health SurveillanceNew England Journal of Medicine, 2009
- Problems with Medication Use in the Elderly: An Australian PerspectiveJournal of Pharmacy Practice and Research, 2006
- Medical and Societal Consequences of the Human Genome ProjectNew England Journal of Medicine, 1999
- Regaining the InitiativeJAMA, 1996